Online citations, reference lists, and bibliographies.
← Back to Search

Prevalence Of Genitourinary Symptoms In The Late Menopause

C. Iosif, Z. Békássy
Published 1984 · Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
Abstract. One thousand two hundred women, aged 61, randomly selected from a defined geographical area in South Sweden, were interviewed by an anonymous questionnaire about their urogenital symptoms. Seventy‐five percent cooperated, of whom 29.2% admitted to some degree of urinary incontinence and 48.8% some degree of lower genital tract disorder. Stress incontinence symptoms were reported by 11.8% of the women, urge incontinence by 7.9% and both types combined—“mixed” by 9.5%. Four percent of all women (18% of stress incontinence) experienced a loss sufficient to necessitate the wearing of a sanitary napkin or change of under clothing several times a day. Thirteen percent had repeated urinary tract infections. Itch, discharge and smarting pain was reported by 15%. Thirty‐eight percent had vaginal dryness and dyspareunia. Only 4% of the women were undergoing estrogen therapy.
This paper references



This paper is referenced by
10.3109/9780203486122-24
Estrogens and urogenital atrophy
D. Robinson (2005)
10.3109/02813439209014051
Oestriol in the prophylactic treatment of recurrent urinary tract infections in postmenopausal women.
A. L. Kirkengen (1992)
10.1177/136218079700300210
Vulval Problems in Postmenopausal Woman
Cm Ridley (1997)
10.1007/s00192-014-2512-9
Pharmacological treatment of pure stress urinary incontinence: a narrative review
M. Malallah (2014)
10.1007/s00441-015-2329-y
Topographies and isoforms of the progesterone receptor in female human, rat and mouse bladder
T. Gevaert (2015)
10.1016/J.MATURITAS.2004.06.019
Self-reported urogenital symptoms in postmenopausal women: Women's Health Initiative.
L. Pastore (2004)
10.3109/00016348709156470
ESTRIOL IN THE POSTMENOPAUSE
G. Heimer (1987)
10.1007/s12325-008-0070-6
Rationale for low-dose systemic hormone replacement therapy and review of estradiol 0.5 mg/NETA 0.1 mg
O. Johansen (2008)
10.1097/gme.0b013e31824e9bb0
Hormone therapy and urinary incontinence.
Milena M. Weinstein (2012)
10.1097/01.GME.0000148645.93603.62
Vaginal estrogen therapy and overactive bladder symptoms in postmenopausal patients after a tension-free vaginal tape procedure: a randomized clinical trial
M. Zullo (2005)
10.1097/SPV.0B013E3181AB4804
Local Effects of Vaginally Administered Estrogen Therapy: A Review.
M. Krause (2009)
10.3109/00016349309068039
Factors influencing vaginal cytology, pH and bacterial flora in elderly women
I. Milsom (1993)
10.1097/GME.0000000000000294
Use of hormone therapy in Swedish women aged 80 years or older
L. Järvstråt (2015)
10.1016/0378-5122(95)01021-1
Nocturnal micturition, sleep and well-being in women of ages 40-64 years.
R. Asplund (1996)
10.1046/j.1464-410x.1999.00022.x
Urinary incontinence in Northern Ireland: a prevalence study
Dolan (1999)
10.1016/S0957-5847(97)80032-7
Clinical symptoms of oestrogen deficiency
D. Sturdee (1997)
10.1177/010740839701700304
Urinary Incontinence among a 65-Year Old Swedish Population: Medical History and Psychosocial Consequences
M. Bogren (1997)
10.1016/J.MATURITAS.2005.05.012
Benefit and safety of 28-day transdermal estrogen regimen during vaginal hysterectomy (a controlled trial).
A. Vesna (2006)
10.1007/s001920070021
Epidemiology and Natural History of Urinary Incontinence
S. Hunskaar (2000)
10.1177/136218079700300212
The Pre-Operative Use of Oestrogen for Vaginal Surgery
R. Obanye (1997)
10.1177/136218070300900309
Assessment of Urinary Incontinence
J. Balmforth (2003)
10.1046/J.1466-7657.2003.00185.X
What do women think about menopause? A qualitative study of women's expectations, apprehensions and knowledge about the climacteric period.
C. Berterö (2003)
10.1016/S1521-690X(02)00085-4
Urogenital effects of hormone therapy
D. Robinson (2003)
10.1080/01443610120059941
Vaginal oestradiol for the treatment of lower urinary tract symptoms in postmenopausal women--a double-blind placebo-controlled study.
L. Cardozo (2001)
10.1093/annonc/mdn353
Practical clinical guidelines for assessing and managing menopausal symptoms after breast cancer.
M. Hickey (2008)
10.1097/MD.0000000000011554
Epidemiology of lower urinary tract symptoms in a cross-sectional, population-based study
J. Wang (2018)
10.1016/S0849-5831(16)30718-2
Towards a Better Recognition of Urogenital Aging
H. Drutz (1996)
10.1016/S0889-8529(18)30042-2
Menopause and the aging female reproductive system.
B. K. Wich (1995)
10.1080/00926230290001529
Systematic Review of Sexual Problems: Epidemiology and Methodology
K. Dunn (2002)
10.1097/GME.0000000000001220
17&bgr;-estradiol vaginal tablet versus conjugated equine estrogen vaginal cream to relieve menopausal atrophic vaginitis
J. Rioux (2018)
10.1016/0378-5122(91)90144-F
Long-term treatment of atrophic vaginitis with low-dose oestradiol vaginal tablets.
L. Mettler (1991)
10.1016/B978-1-4160-2339-5.50054-9
Chapter 5 – HORMONAL INFLUENCES ON THE FEMALE GENITAL AND LOWER URINARY TRACTS
D. Robinson (2008)
See more
Semantic Scholar Logo Some data provided by SemanticScholar